Fig. 3From: Characteristics and clinical treatment outcomes of chronic hepatitis B children with coexistence of hepatitis B surface antigen (HBsAg) and antibodies to HBsAgSubgroup analyses of the HR (95% CI) of treatment outcomes according to HBsAb status. The models were adjusted for age, gender, baseline HBsAg, HBeAg, HBV DNA, ALT, and ASTBack to article page